collection
https://read.qxmd.com/read/31704148/an-algorithmic-approach-to-the-interpretation-of-diffuse-lung-disease-on-chest-ct-imaging-a-theory-of-almost-everything
#1
REVIEW
James F Gruden, David P Naidich, Stephen C Machnicki, Stuart L Cohen, Francis Girvin, Suhail Raoof
We propose an algorithmic approach to the interpretation of diffuse lung disease on high-resolution CT. Following an initial review of pertinent lung anatomy, the following steps are included. Step 1: a preliminary review of available chest radiographs, including the "scanogram" obtained at the time of the CT examination. Step 2: a review of optimal methods of data acquisition and reconstruction, emphasizing the need for contiguous high-resolution images throughout the entire thorax. Step 3: initial uninterrupted scrolling of contiguous high-resolution images throughout the chest to establish the quality of examination as well as an overview of the presence and extent of disease...
March 2020: Chest
https://read.qxmd.com/read/31211108/update-on-screening-for-lung-cancer
#2
REVIEW
Douglas Arenberg
As the leading cause of cancer related death world wide, lung cancer is responsible for an enormous amount of suffering and disability. Detection of disease when it is surgically curable is associated with far greater odds of cure, and therefore it is a disease for which mass screening of high-risk populations has significant potential benefit. Starting in 2011, with the publication of the National Lung Screening Trial from United States (U.S.), mass screening programs have emerged throughout the U.S., as well as in other countries...
May 2019: Translational Lung Cancer Research
https://read.qxmd.com/read/31249014/gina-2019-a-fundamental-change-in-asthma-management-treatment-of-asthma-with-short-acting-bronchodilators-alone-is-no-longer-recommended-for-adults-and-adolescents
#3
EDITORIAL
Helen K Reddel, J Mark FitzGerald, Eric D Bateman, Leonard B Bacharier, Allan Becker, Guy Brusselle, Roland Buhl, Alvaro A Cruz, Louise Fleming, Hiromasa Inoue, Fanny Wai-San Ko, Jerry A Krishnan, Mark L Levy, Jiangtao Lin, Søren E Pedersen, Aziz Sheikh, Arzu Yorgancioglu, Louis-Philippe Boulet
No abstract text is available yet for this article.
June 2019: European Respiratory Journal
https://read.qxmd.com/read/30985211/acute-treatment-of-pulmonary-embolism-part-2
#4
JOURNAL ARTICLE
Parth Rali, Viral Gandhi, Marianna Sockrider
No abstract text is available yet for this article.
April 15, 2019: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/30636373/benefits-of-non-invasive-ventilation-in-acute-hypercapnic-respiratory-failure
#5
REVIEW
Vittoria Comellini, Angela Maria Grazia Pacilli, Stefano Nava
Non-invasive ventilation (NIV) with bilevel positive airway pressure is a non-invasive technique, which refers to the provision of ventilatory support through the patient's upper airway using a mask or similar device. This technique is successful in correcting hypoventilation. It has become widely accepted as the standard treatment for patients with hypercapnic respiratory failure (HRF). Since the 1980s, NIV has been used in intensive care units and, after initial anecdotal reports and larger series, a number of randomized trials have been conducted...
April 2019: Respirology: Official Journal of the Asian Pacific Society of Respirology
https://read.qxmd.com/read/30658650/interstitial-lung-disease-associated-with-systemic-sclerosis-ssc-ild
#6
REVIEW
Vincent Cottin, Kevin K Brown
BACKGROUND: Systemic sclerosis (SSc) is a rare connective tissue disease with a heterogeneous clinical course. Interstitial lung disease (ILD) is a common manifestation of SSc and a leading cause of death. MAIN BODY: All patients newly diagnosed with SSc should receive a comprehensive clinical evaluation, including assessment of respiratory symptoms, a high-resolution computed tomography (HRCT) scan of the chest, and pulmonary function tests. ILD can develop in any patient with SSc, including those with pulmonary hypertension, but the risk is increased in those with diffuse (rather than limited) cutaneous SSc, those with anti-Scl-70/anti-topoisomerase I antibody, and in the absence of anti-centromere antibody...
January 18, 2019: Respiratory Research
https://read.qxmd.com/read/30468277/non-invasive-ventilation-essential-requirements-and-clinical-skills-for-successful-practice
#7
REVIEW
Mark W Elliott
Audits and case reviews of the acute delivery of non-invasive ventilation (NIV) have shown that the results achieved in real life often fall short of those achieved in research trials. Factors include inappropriate selection of patients for NIV and failure to apply NIV correctly. This highlights the need for proper training of all involved individuals. This article addresses the different skills needed in a team to provide an effective NIV service. Some detail is given in each of the key areas but it is not comprehensive and should stimulate further learning (reading, attendance on courses, e-learning, etc...
December 2019: Respirology: Official Journal of the Asian Pacific Society of Respirology
https://read.qxmd.com/read/30500099/high-intensity-non-invasive-ventilation-in-stable-hypercapnic-copd-evidence-of-efficacy-and-practical-advice
#8
REVIEW
Sietske van der Leest, Marieke L Duiverman
Patients with end-stage chronic obstructive pulmonary disease (COPD) frequently develop chronic hypercapnic respiratory failure (CHRF), with disabling symptoms and poor survival. The use of long-term nocturnal non-invasive ventilation (NIV) to treat CHRF in COPD has long been subject of debate due to conflicting evidence. However, since the introduction of high-intensity NIV (HI-NIV) in COPD, physiological and clinical benefits have been shown. HI-NIV refers to specific ventilator settings used for NIV aimed at achieving normocapnia or the lowest partial arterial carbon dioxide pressure (PaCO2 ) values as possible...
April 2019: Respirology: Official Journal of the Asian Pacific Society of Respirology
https://read.qxmd.com/read/30528423/acute-lobar-atelectasis
#9
REVIEW
John J Marini
Lobar atelectasis (or collapse) is an exceedingly common, rather predictable, and potentially pathogenic companion to many forms of acute illness, postoperative care, and chronic debility. Readily diagnosed by using routine chest imaging and bedside ultrasound, the consequences from lobar collapse may be minor or serious, depending on extent, mechanism, patient vulnerability, abruptness of onset, effectiveness of hypoxic vasoconstriction, and compensatory reserves. Measures taken to reduce secretion burden, assure adequate secretion clearance, maintain upright positioning, reverse lung compression, and sustain lung expansion accord with a logical physiologic rationale...
May 2019: Chest
https://read.qxmd.com/read/30272503/management-of-malignant-pleural-effusions-an-official-ats-sts-str-clinical-practice-guideline
#10
JOURNAL ARTICLE
David J Feller-Kopman, Chakravarthy B Reddy, Malcolm M DeCamp, Rebecca L Diekemper, Michael K Gould, Travis Henry, Narayan P Iyer, Y C Gary Lee, Sandra Z Lewis, Nick A Maskell, Najib M Rahman, Daniel H Sterman, Momen M Wahidi, Alex A Balekian
BACKGROUND: This Guideline, a collaborative effort from the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic Radiology, aims to provide evidence-based recommendations to guide contemporary management of patients with a malignant pleural effusion (MPE). METHODS: A multidisciplinary panel developed seven questions using the PICO (Population, Intervention, Comparator, and Outcomes) format. The GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and the Evidence to Decision framework was applied to each question...
October 1, 2018: American Journal of Respiratory and Critical Care Medicine
https://read.qxmd.com/read/29968985/guideline-for-antibiotic-use-in-adults-with-community-acquired-pneumonia
#11
REVIEW
Mi Suk Lee, Jee Youn Oh, Cheol In Kang, Eu Suk Kim, Sunghoon Park, Chin Kook Rhee, Ji Ye Jung, Kyung Wook Jo, Eun Young Heo, Dong Ah Park, Gee Young Suh, Sungmin Kiem
Community-acquired pneumonia is common and important infectious disease in adults. This work represents an update to 2009 treatment guideline for community-acquired pneumonia in Korea. The present clinical practice guideline provides revised recommendations on the appropriate diagnosis, treatment, and prevention of community-acquired pneumonia in adults aged 19 years or older, taking into account the current situation regarding community-acquired pneumonia in Korea. This guideline may help reduce the difference in the level of treatment between medical institutions and medical staff, and enable efficient treatment...
June 2018: Infection & Chemotherapy
https://read.qxmd.com/read/29962118/pneumonia-in-patients-with-chronic-obstructive-pulmonary-disease
#12
REVIEW
Marcos I Restrepo, Oriol Sibila, Antonio Anzueto
Chronic obstructive pulmonary disease (COPD) is a frequent comorbid condition associated with increased morbidity and mortality. Pneumonia is the most common infectious disease condition. The purpose of this review is to evaluate the impact of pneumonia in patients with COPD. We will evaluate the epidemiology and factors associated with pneumonia. We are discussing the clinical characteristics of COPD that may favor the development of infections conditions such as pneumonia. Over the last 10 years, there is an increased evidence that COPD patients treated with inhaled corticosteroids are at increased risk to develp pneumonia...
July 2018: Tuberculosis and Respiratory Diseases
https://read.qxmd.com/read/29898978/british-thoracic-society-guideline-for-the-initial-outpatient-management-of-pulmonary-embolism-pe
#13
REVIEW
Luke S G E Howard, Steven Barden, Robin Condliffe, Vincent Connolly, Christopher W H Davies, James Donaldson, Bernard Everett, Catherine Free, Daniel Horner, Laura Hunter, Jasvinder Kaler, Catherine Nelson-Piercy, Emma O-Dowd, Raj Patel, Wendy Preston, Karen Sheares, Tait Campbell
No abstract text is available yet for this article.
July 2018: Thorax
https://read.qxmd.com/read/29461885/physiologic-basis-of-mechanical-ventilation
#14
JOURNAL ARTICLE
Martin J Tobin
The primary purpose of mechanical ventilation is to decrease work of breathing. Achieving this goal requires that cycling of the ventilator be carefully aligned with the intrinsic rhythm of a patient's respiratory center output. Problems arise at the point of ventilator triggering, post-trigger inflation, and inspiration-expiration switchover. Careful, iterative adjustments of ventilator settings are required to minimize work of breathing. Use of protocols for the selection of ventilator settings can lead to complications (including alveolar overdistention) and risk of death...
February 2018: Annals of the American Thoracic Society
https://read.qxmd.com/read/29524387/considerations-for-the-correct-diagnosis-of-copd-and-its-management-with-bronchodilators
#15
JOURNAL ARTICLE
Antonio Anzueto, Marc Miravitlles
COPD is often misdiagnosed and inappropriately treated in many patients. COPD is a distinct disease from adult-onset asthma; however, some patients with COPD may present with several forms of airway disease described as asthma-COPD overlap (ACO). Bronchodilators and inhaled corticosteroids (ICS) both have a place in standard maintenance treatment of COPD and asthma; however, recommendations for use differ widely. In patients with COPD, long-acting bronchodilators are effective initial monotherapy treatment, whereas ICS monotherapy is recommended as initial treatment in patients with asthma...
August 2018: Chest
https://read.qxmd.com/read/29471816/idiopathic-pulmonary-fibrosis-pathogenesis-and-management
#16
REVIEW
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi
BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease characterized by the aberrant accumulation of fibrotic tissue in the lungs parenchyma, associated with significant morbidity and poor prognosis. This review will present the substantial advances achieved in the understanding of IPF pathogenesis and in the therapeutic options that can be offered to patients, and will address the issues regarding diagnosis and management that are still open. MAIN BODY: Over the last two decades much has been clarified about the pathogenic pathways underlying the development and progression of the lung scarring in IPF...
February 22, 2018: Respiratory Research
https://read.qxmd.com/read/29438523/reconsidering-treatment-of-community-acquired-pneumonia-are-macrolides-plus-%C3%AE-lactams-essential
#17
LETTER
Harold W Horowitz
No abstract text is available yet for this article.
July 18, 2018: Clinical Infectious Diseases
https://read.qxmd.com/read/28617305/fibrotic-hypersensitivity-pneumonitis-key-issues-in-diagnosis-and-management
#18
REVIEW
Vasileios Kouranos, Joseph Jacob, Andrew Nicholson, Elizabetta Renzoni
The diagnosis of hypersensitivity pneumonitis (HP) relies on the clinical evaluation of a number of features, including a history of significant exposure to potentially causative antigens, physical examination, chest CT scan appearances, bronchoalveolar lavage lymphocytosis, and, in selected cases, histology. The presence of fibrosis is associated with higher morbidity and mortality. Differentiating fibrotic HP from the idiopathic interstitial pneumonias can be a challenge. Furthermore, even in the context of a clear diagnosis of fibrotic HP, the disease behaviour can parallel that of idiopathic pulmonary fibrosis in a subgroup, with inexorable progression despite treatment...
June 15, 2017: Journal of Clinical Medicine
https://read.qxmd.com/read/28513453/chronic-obstructive-pulmonary-disease
#19
REVIEW
Klaus F Rabe, Henrik Watz
Chronic obstructive pulmonary disease (COPD) kills more than 3 million people worldwide every year. Despite progress in the treatment of symptoms and prevention of acute exacerbations, few advances have been made to ameliorate disease progression or affect mortality. A better understanding of the complex disease mechanisms resulting in COPD is needed. Smoking cessation programmes, increasing physical activity, and early detection and treatment of comorbidities are further key components to reduce the burden of the disease...
May 13, 2017: Lancet
https://read.qxmd.com/read/28286407/pulmonary-hypertension-associated-with-idiopathic-pulmonary-fibrosis-current-and-future-perspectives
#20
REVIEW
Scott D Collum, Javier Amione-Guerra, Ana S Cruz-Solbes, Amara DiFrancesco, Adriana M Hernandez, Ankit Hanmandlu, Keith Youker, Ashrith Guha, Harry Karmouty-Quintana
Pulmonary hypertension (PH) is commonly present in patients with chronic lung diseases such as Chronic Obstructive Pulmonary Disease (COPD) or Idiopathic Pulmonary Fibrosis (IPF) where it is classified as Group III PH by the World Health Organization (WHO). PH has been identified to be present in as much as 40% of patients with COPD or IPF and it is considered as one of the principal predictors of mortality in patients with COPD or IPF. However, despite the prevalence and fatal consequences of PH in the setting of chronic lung diseases, there are limited therapies available for patients with Group III PH, with lung transplantation remaining as the most viable option...
2017: Canadian Respiratory Journal: Journal of the Canadian Thoracic Society
label_collection
label_collection
7377
1
2
2017-03-28 20:27:50
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.